Serum lipid profile, sleep-disordered breathing and blood pressure in the elderly: a 10-year follow-up of the PROOF-SYNAPSE cohort

Sleep Medicine

Volumn 39, Issue , 2017, Pages 14-22

  Monneret, Denis ^a   Barthélémy, Jean Claude ^b   Hupin, David ^b   Maudoux, Delphine ^b   Celle, Sébastien ^b   Sforza, Emilia ^b   Roche, Frédéric ^b  

^a HÔPITAL CHARLES FOIX   (France)

^b UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

Blood pressure; Elderly; Oxygen desaturation; Serum lipids; Sleep disordered breathing

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXYGEN;

AGED; AGING; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OXYGEN DESATURATION; OXYGEN SATURATION; PREVALENCE; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO; BLOOD PRESSURE; COMPLICATION; PHYSIOLOGY; POLYSOMNOGRAPHY; PROSPECTIVE STUDY; RISK FACTOR;

AGED; BLOOD PRESSURE; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; POLYSOMNOGRAPHY; PROSPECTIVE STUDIES; RISK FACTORS; SLEEP APNEA SYNDROMES;

EID: 85031820852     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2017.07.028     Document Type: Article

References (49)

1. Otsuka, T., Takada, H., Nishiyama, Y., et al. Dyslipidemia and the risk of developing hypertension in a working-age male population. J Am Heart Assoc, 5(3), 2016, e003053.
2. Laaksonen, D.E., Niskanen, L., Nyyssönen, K., et al. Dyslipidaemia as a predictor of hypertension in middle-aged men. Eur Heart J 29:20 (2008), 2561–2568.
3. Kit, B.K., Kuklina, E., Carroll, M.D., et al. Prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999-2012. JAMA Pediatr 169:3 (2015), 272–279.
4. Wildman, R.P., Sutton-Tyrrell, K., Newman, A.B., et al. Lipoprotein levels are associated with incident hypertension in older adults. J Am Geriatr Soc 52:6 (2004), 916–921.
5. Masoura, C., Pitsavos, C., Aznaouridis, K., et al. Arterial endothelial function and wall thickness in familial hypercholesterolemia and familial combined hyperlipidemia and the effect of statins. A systematic review and meta-analysis. Atherosclerosis 214:1 (2011), 129–138.
6. Lambert, E., Straznicky, N., Sari, C.I., et al. Dyslipidemia is associated with sympathetic nervous activation and impaired endothelial function in young females. Am J Hypertens 26:2 (2013), 250–256.
7. Qian, Y., Yi, H., Zou, J., et al. Independent association between sleep fragmentation and dyslipidemia in patients with obstructive sleep apnea. Sci Rep, 6, 2016, 26089.
8. Trzepizur, W., Le Vaillant, M., Meslier, N., et al., Institut de Recherche en Santé Respiratoire des Pays de la Loire (IRSR) Sleep Cohort Group. Independent association between nocturnal intermittent hypoxemia and metabolic dyslipidemia. Chest 143:6 (2013), 1584–1589.
9. Kawano, Y., Tamura, A., Kadota, J., Association between the severity of obstructive sleep apnea and the ratio of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol. Metabolism 61:2 (2012), 186–192.
10. Drager, L.F., Jun, J.C., Polotsky, V.Y., Metabolic consequences of intermittent hypoxia: relevance to obstructive sleep apnea. Best Pract Res Clin Endocrinol Metab 24:5 (2010), 843–851.
11. Drager, L.F., Jun, J., Polotsky, V.Y., Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis. Curr Opin Endocrinol Diabetes Obes 17:2 (2010), 161–165.
12. Kiely, J.L., McNicholas, W.T., Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Respir J 16:1 (2000), 128–133.
13. Nieto, F.J., Young, T.B., Lind, B.K., et al. For the Sleep Heart Health Study. Association of sleep-disordered breathing, sleep apnea and hypertension in a large community-based study. JAMA 283:14 (2000), 1829–1836.
14. Mokhlesi, B., Ham, S.A., Gozal, D., The effect of sex and age on the comorbidity burden of OSA: an observational analysis from a large nationwide US health claims database. Eur Respir J 47:4 (2016), 1162–1169.
15. Guillot, M., Sforza, E., Achour-Crawford, E., et al. Association between severe obstructive sleep apnea and incident arterial hypertension in the older people population. Sleep Med 14:9 (2013), 838–842.
16. Roche, F., Sforza, E., Pichot, V., et al., PROOF Study Group. Obstructive sleep apnoea/hypopnea influences high-density lipoprotein cholesterol in the elderly. Sleep Med 10:8 (2009), 882–886.
17. Barthelemy, J.C., Pichot, V., Dauphinot, V., et al. Autonomic nervous system activity and decline as prognostic indicators of cardiovascular and cerebrovascular events: the PROOF study. Neuroepidemiology 29:1–2 (2007), 18–28.
18. Mancia, G., De Backer, G., Dominiczak, A., et al., ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens 25:9 (2007), 1751–1762.
19. Anon, Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 22:5 (1999), 667–689.
20. Jellinger, P.S., Smith, D.A., Mehta, A.E., et al., AACE Task Force. American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. Endocr Pract 18:Suppl. 1 (2012), 1–78.
21. Neter, J., Kutner, M.H., Nachtsheim, C.J., et al. Applied linear statistical models. 4th ed., 1996, McGraw-Hill, Boston.
22. Cao, Z., Zhang, P., He, Z., et al. Obstructive sleep apnea combined dyslipidemia render additive effect on increasing atherosclerotic cardiovascular diseases prevalence. Lipids Health Dis, 15, 2016, 98.
23. Xu, H., Guan, J., Yi, H., et al., Shanghai Sleep Health Study Research Group. Elevated low-density lipoprotein cholesterol is independently associated with obstructive sleep apnea: evidence from a large-scale cross-sectional study. Sleep Breath 20:2 (2016), 627–634.
24. Ng, G., Boey, E., Frampton, C., et al. Obstructive sleep apnea is associated with visit-to-visit variability in low-density lipoprotein-cholesterol in patients with coronary artery disease. Sleep Breath 21:2 (2017), 271–278.
25. Guan, J., Yi, H., Zou, J., et al., Shanghai Sleep Health Study Research Group. Distinct severity stages of obstructive sleep apnoea are correlated with unique dyslipidaemia: large-scale observational study. Thorax 71:4 (2016), 347–355.
26. Nadeem, R., Singh, M., Nida, M., et al. Effect of obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis. J Clin Sleep Med 10:5 (2014), 475–489.
27. Assoumou, H.G., Gaspoz, J.M., Sforza, E., et al. Obstructive sleep apnea and the metabolic syndrome in an elderly healthy population: the SYNAPSE cohort. Sleep Breath 16:3 (2012), 895–902.
28. Xu, H., Yi, H., Guan, J., et al. Effect of continuous positive airway pressure on lipid profile in patients with obstructive sleep apnea syndrome: a meta-analysis of randomized controlled trials. Atherosclerosis 234:2 (2014), 446–453.
29. Lin, M.T., Lin, H.H., Lee, P.L., et al. Beneficial effect of continuous positive airway pressure on lipid profiles in obstructive sleep apnea: a meta-analysis. Sleep Breath 19:3 (2015), 809–817.
30. McMillan, A., Bratton, D.J., Faria, R., et al., PREDICT Investigators. Continuous positive airway pressure in older people with obstructive sleep apnoea syndrome (PREDICT): a 12-month, multicentre, randomised trial. Lancet Respir Med 2:10 (2014), 804–812.
31. McMillan, A., Bratton, D.J., Faria, R., et al. A multicentre randomised controlled trial and economic evaluation of continuous positive airway pressure for the treatment of obstructive sleep apnoea syndrome in older people: PREDICT. Health Technol Assess 19:40 (2015), 1–188.
32. Huang, Z., Liu, Z., Zhao, Z., et al. Effects of continuous positive airway pressure on lipidaemia and high-sensitivity C-reactive protein levels in non-obese patients with coronary artery disease and obstructive sleep apnoea. Heart Lung Circ 25:6 (2016), 576–583.
33. O'Brien, E.C., Wu, J., Schulte, P.J., et al. Statin use, intensity, and 3-year clinical outcomes among older patients with coronary artery disease. Am Heart J 173 (2016), 27–34.
34. Natsuaki, M., Morimoto, T., Furukawa, Y., et al. Effect of statin therapy on cardiovascular outcomes after coronary revascularization in patients ≥80 years of age: observations from the CREDO-Kyoto Registry Cohort-2. Atherosclerosis 237:2 (2014), 821–828.
35. Teng, M., Lin, L., Zhao, Y.J., et al. Statins for primary prevention of cardiovascular disease in elderly patients: systematic review and meta-analysis. Drugs Aging 32:8 (2015), 649–661.
36. Savarese, G., Gotto, A.M. Jr., Paolillo, S., et al. Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis. J Am Coll Cardiol 62:22 (2013), 2090–2099.
37. Yamaguchi, T., Takata, Y., Usui, Y., et al. Nocturnal intermittent hypoxia is associated with left ventricular hypertrophy in middle-aged men with hypertension and obstructive sleep apnea. Am J Hypertens 29:3 (2016), 372–378.
38. Sforza, E., Sabri, M., DaCosta, A., et al. Echocardiographic findings in healthy elderly people with unrecognized sleep disordered breathing. J Clin Sleep Med 11:9 (2015), 975–980.
39. Tsapanou, A., Gu, Y., O'Shea, D., et al. Self-reported sleep disordered breathing as risk factor for mortality in the elderly. J Stroke Cerebrovasc Dis 25:6 (2016), 1524–1531.
40. Banach, M., Bromfield, S., Howard, G., et al. Association of systolic blood pressure levels with cardiovascular events and all-cause mortality among older adults taking antihypertensive medication. Int J Cardiol 176:1 (2014), 219–226.
41. Strazzullo, P., Kerry, S.M., Barbato, A., et al. Do statins reduce blood pressure?: a meta-analysis of randomized, controlled trials. Hypertension 49:4 (2007), 792–798.
42. Kawasaki, T., Sullivan, C.V., Ozoe, N., et al. A long-term, comprehensive exercise program that incorporates a variety of physical activities improved the blood pressure, lipid and glucose metabolism, arterial stiffness, and balance of middle-aged and elderly Japanese. Hypertens Res 34:9 (2011), 1059–1066.
43. Crapo, R.O., Jensen, R.L., Hegewald, M., et al. Arterial blood gas reference values for sea level and an altitude of 1,400 meters. Am J Respir Crit Care Med 160:5 Pt 1 (1999), 1525–1531.
44. Klæstrup, E., Trydal, T., Pedersen, J.F., et al. Reference intervals and age and gender dependency for arterial blood gases and electrolytes in adults. Clin Chem Lab Med 49:9 (2011), 1495–1500.
45. Delclaux, B., Orcel, B., Housset, B., et al. Arterial blood gases in elderly persons with chronic obstructive pulmonary disease (COPD). Eur Respir J 7:5 (1994), 856–861.
46. Guénard, H., Marthan, R., Pulmonary gas exchange in elderly subjects. Eur Respir J 9:12 (1996), 2573–2577.
47. Hardie, J.A., Vollmer, W.M., Buist, A.S., et al. Reference values for arterial blood gases in the elderly. Chest 125:6 (2004), 2053–2060.
48. Cerveri, I., Zoia, M.C., Fanfulla, F., et al. Reference values of arterial oxygen tension in the middle-aged and elderly. Am J Respir Crit Care Med 152:3 (1995), 934–941.
49. Blom, H.J., Mulder, M.F., Verweij, W.M., The effect of age and activity on arterial oxygen pressure and arterial oxygen saturation in hospitalized patients. Ned Tijdschr Geneeskd 133:21 (1989), 1080–1083.